Acadia Pharmaceuticals Inc Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 4.60M42.13M2.07M4.91M1.15M0.12M0.06M17.33M124.90M223.81M339.08M441.75M484.14M517.24M726.44M957.80M
Cost of Revenue 3.08M9.08M12.38M11.34M10.21M19.14M10.17M41.64M81.84M
Gross Profit 4.60M42.13M2.07M4.91M1.15M0.12M0.06M14.26M115.82M211.43M327.73M431.54M465.00M507.07M684.80M875.96M
Operating items
Research & Development 41.59M20.58M17.31M18.79M26.72M60.60M73.87M99.28M149.19M187.16M240.38M319.13M239.41M361.57M351.62M303.25M
Selling, General & Administrative 10.28M6.46M7.61M7.00M12.72M32.75M88.30M186.46M255.06M265.76M325.64M388.66M396.03M369.09M406.56M488.43M
Other Operating Expenses 2.50M4.41M13.06M18.33M19.60M20.55M19.14M10.17M41.64M146.51M
Operating Expenses 51.87M27.04M24.92M25.79M39.44M93.35M164.67M290.15M417.31M471.25M585.62M728.34M654.58M740.83M799.82M727.00M
Operating Income -45.47M15.09M-22.85M-20.89M-38.30M-93.23M-164.61M-272.81M-292.41M-247.44M-246.54M-286.59M-170.44M-223.60M-73.38M230.79M
EBIT -45.47M15.09M-22.85M-20.89M-38.30M-93.23M-164.61M-272.81M-292.41M-247.44M-246.54M-286.59M-170.44M-223.60M-73.38M230.79M
Non-operating items
Interest & Investment Income 0.32M0.04M0.09M0.04M0.35M0.76M0.50M2.76M4.13M5.35M11.16M6.61M0.59M6.61M17.23M25.46M
Other Non Operating Income -1.84M1.00M-1.00M2.33M3.54M5.11M1.82M
Non Operating Income 0.00M48.46M64.06M61.48M20.90M20.41M4.21M2.86M3.54M5.11M-13.71M
Net income details
EBT -45.06M15.18M-22.77M-20.85M-37.95M-92.47M-164.11M-270.05M-288.28M-243.94M-234.38M-280.97M-167.52M-213.44M-51.04M258.07M
Tax Provisions 0.33M1.34M1.12M1.30M0.90M0.61M0.35M2.53M10.30M31.62M
Profit After Tax 45.15M15.14M-22.77M-20.85M-37.95M-92.47M-164.44M-271.39M-289.40M-245.19M-235.26M-281.58M-167.87M-215.97M-61.29M226.45M
Income from Continuing Operations -45.06M15.18M-22.77M-20.85M-37.95M-92.47M-164.44M-271.39M-289.40M-245.24M-235.28M-281.58M-167.87M-215.97M-61.34M226.45M
Consolidated Net Income -45.06M15.18M-22.77M-20.85M-37.95M-92.47M-164.44M-271.39M-289.40M-245.24M-235.28M-281.58M-167.87M-215.97M-61.34M226.45M
Income towards Parent Company -45.06M15.18M-22.77M-20.85M-37.95M-92.47M-164.44M-271.39M-289.40M-245.24M-235.28M-281.58M-167.87M-215.97M-61.34M226.45M
Net Income towards Common Stockholders -45.06M15.18M-22.77M-20.85M-37.95M-92.47M-164.44M-271.39M-289.40M-245.24M-235.28M-281.58M-167.87M-215.97M-61.29M226.45M
Additional items
EPS (Basic) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 38.27M39.30M52.80M78.76M90.87M100.17M100.91M121.11M124.70M125.07M154.03M160.05M160.76M162.23M164.18M166.39M
Shares Outstanding (Diluted Average) 37.48M38.72M52.18M55.12M0.16M0.16M161.68M163.82M166.36M
EBITDA -45.47M15.09M-22.85M-20.89M-38.30M-93.23M-164.61M-272.81M-292.41M-247.44M-246.54M-286.59M-170.44M-223.60M-73.38M230.79M
Tax Rate 12.25%